Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a mid-cap US stock, returning 12,497.4%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 12,497.44% |
Sezzle Inc Common Stock (SEZL) | 204.39% |
Oklo (OKLO) | 155.58% |
Dave (DAVE) | 154.67% |
TransMedics (TMDX) | 117.81% |
Centrus Energy (LEU) | 116.35% |
D-Wave Quantum (QBTS) | 111.18% |
Root (ROOT) | 108.79% |
Sibanye Gold Ltd ADR (SBSW) | 100.59% |
Akero Therapeutics (AKRO) | 94.84% |
New Gold (NGD) | 93.63% |
Orla Mining (ORLA) | 93.59% |
H&E Equipment Services (HEES) | 91.21% |
Nuscale Power (SMR) | 89.77% |
Nebius (NBIS) | 86.92% |
SSR Mining (SSRM) | 81.68% |
Verona Pharma PLC ADR (VRNA) | 81.16% |
Harmony Gold Mining (HMY) | 78.52% |
MP Materials (MP) | 74.7% |
Soleno Therapeutics (SLNO) | 73.5% |
Ascentage Pharma Group International (AAPG) | 73.22% |
Metsera, Inc Common Stock (MTSR) | 68.83% |
Inter & Co Inc Class A Common Shares (INTR) | 66.33% |
Applied Digital (APLD) | 65.86% |
Companhia Paranaense de Energia - COPEL (ELPC) | 65.72% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
